Podcasts about Roche

  • 2,569PODCASTS
  • 12,985EPISODES
  • 19mAVG DURATION
  • 1DAILY NEW EPISODE
  • Aug 2, 2025LATEST

POPULARITY

20172018201920202021202220232024

Categories



Best podcasts about Roche

Show all podcasts related to roche

Latest podcast episodes about Roche

Diabetes Connections with Stacey Simms Type 1 Diabetes
In the News.. A new insulin approved, DOJ rules on CGM in schools, T2D artificial sweetener study, and more!

Diabetes Connections with Stacey Simms Type 1 Diabetes

Play Episode Listen Later Aug 1, 2025 7:34


It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: FDA approves the first fast-acting biosimilar insulin in the US, Tandem issues warning, DOJ stands up for remote monitoring in schools, GLP1 use protects against dementia, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX We've got the first and only biosimilar FDA approved and moving to market. Kirsty – insulin aspart, which is a biosimilar to Novolog will be available as a single-patient-use prefilled pen for subcutaneous use and a multiple-dose vial for subcutaneous and intravenous use. KIRSTY has been available in Europe and Canada since 2022. This same company makes Semglee, the first biosimilar for long acting? Sales of Insulin Aspart in the United States were approximately $1.9 billion in 2024, according to IQVIA. https://www.globenewswire.com/news-release/2025/07/15/3115973/0/en/Biocon-Biologics-Expands-Diabetes-Portfolio-with-FDA-Approval-of-Kirsty-the-First-and-Only-Interchangeable-Rapid-Acting-Insulin-Aspart-in-the-United-States.html XX Tandem Diabetes Care (Nasdaq:TNDM) has issued an urgent medical device correction for some t:slim X2 automated insulin pumps. In a July 22 notice, the San Diego-based company warned of pumps that may exhibit a higher rate of speaker failure. During normal use, the insulin pump software monitors current flowing through the speaker during use. Measurements that fall within a pre-determined range indicate a functioning speaker. Meanwhile, measurements falling outside the range indicate a speaker failure.   When the measurements land outside the expected range, the system declares a malfunction, referred to as “Malfunction 16.” If the pump declares this malfunction, insulin delivery will stop and the pump will no longer be operational. Malfunction 16 terminates communication between the pump and continuous glucose monitor (CGM), as well as the t:slim mobile app.   If not addressed, the issue can lead to hyperglycemia, which can result in hospitalization or medical intervention. The company reports 700 adverse events and 59 reported injuries to date, with no reports of death.   Tandem identified that certain speaker versions have a higher rate of Malfunction 16 events due to a wiring issue within the speaker. Users can continue using their pump but with added precautions because Malfunction 16 can occur at any time. They should use the t:slim mobile app with push notifications turned on so the app alerts them if the malfunction occurs, the company said.   Additionally, Tandem intends to release a software update aimed at enhancing the early detection of speaker failure. The update also introduces persistent vibration alarms to help reduce potential safety risk. Tandem plans to notify affected pump users when it makes the update available. https://www.drugdeliverybusiness.com/tandem-warns-insulin-pump-speaker-malfunction/ XX BIG WIN! The DOJ protects T1D rights again! The US Attorney's office for the Western District of Washington State reached a settlement with a public school district that once again confirms remotely monitoring students' CGMs is a reasonable accommodation that schools must provide to comply with the Americans with Disabilities Act. If its true for one state its true for all states under federal law! If your local schools still refuse to remotely monitor CGMs of their students, provide them with this letter to compel them to FOLLOWT1Ds and FOLLOW Federal Laws. If they still refuse contact us! https://followt1ds.org/ XX new study finds people taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin users. Past studies show that people who have type 2 diabetes — a chronic condition where the body does not use its insulin properly — are at a higher risk of developing dementia. The study found that when comparing the neuroprotective abilities of two diabetes medications — metformin and glucagon-like peptide-1 receptor agonists (GLP-1 agonists) — participants taking GLP-1 agonists had a significantly lower cumulative risk of developing dementia, when compared to metformin.   https://www.medicalnewstoday.com/articles/glp-1s-may-offer-better-dementia-protection-than-metformin XX Front office changes coming to Dexcom.  CEO Kevin Sayer will step down  & give the reins to current Chief Operating Officer Jake Leach. Scheduled for January 1, 2026, Leach will also join Dexcom's board of directors where Sayer will remain  executive chairman. One of our frequent guests here.. Leach has worked at Dexcom for 21 years. He served as chief technology officer from 2018 to 2022 before he was named COO in late 2022. He was given the title of president in May. https://www.medtechdive.com/news/dexcom-ceo-change-kevin-sayer-jake-leach/756382/ XX A major international study has revealed that many children and young adults in Sub-Saharan Africa who are diagnosed with type 1 diabetes (T1D) may actually have a different, non-immune-based form of the condition. Unlike the traditional autoimmune version of T1D, this form appears to develop without the immune system attacking the insulin-producing cells. This finding could significantly reshape how diabetes is diagnosed and treated across the region, potentially leading to more precise care and better health outcomes. The researchers found that many young people in Sub-Saharan Africa diagnosed with T1D often don't have the usual markers in their blood (called islet autoantibodies) typically seen in people with T1D in other parts of the world. Specifically, 65% of participants with T1D in this region did not have islet autoantibodies. When the researchers compared this data to studies in the U.S., they found a smaller but significant proportion (15%) of Black participants diagnosed with T1D had a similar form of diabetes found in Sub-Saharan Africa – characterized by negative autoantibodies and a low T1D genetic risk score.   However, white Americans with T1D showed the typical autoimmune pattern, even if they didn't have detectable autoantibodies, their genetics still pointed to autoimmune diabetes.   “The identification of this T1D diabetes subtype in Sub-Saharan African populations and among individuals of African ancestry in the U.S. suggests a potential ancestral or genetic link,” Dabelea notes. “These findings highlight the need to consider alternative etiologies in this group and a deeper understanding of the underlying mechanisms may provide important insights for future prevention and treatment strategies.”     https://scitechdaily.com/new-diabetes-subtype-discovered-in-africa-challenges-global-assumptions/   XX Formal recognition for the specialty of Diabetology.   Diabetology is the specialty focused on the full continuum of diabetes care — encompassing diagnosis, treatment, prevention, technology integration, education, and cardiometabolic management. While it intersects with endocrinology, primary care, and public health, diabetology is uniquely defined by its depth and focus on diabetes alone.       The American College of Diabetology (ACD) is the national professional organization representing clinicians who specialize in diabetes care. ACD advances clinical excellence and education to improve the lives of those affected by diabetes. https://www.businesswire.com/news/home/20250725766248/en/American-College-of-Diabetology-Announces-Formal-Taxonomy-Classification-for-Diabetology   XX Tidepool announces cloud-to-cloud integration with Abbott's FreeStyle Libre portfolio. From the release: This integration allows people living with diabetes using the FreeStyle Libre portfolio to connect their data to their Tidepool account seamlessly. For healthcare providers, this means more comprehensive insights and streamlined workflows, with FreeStyle Libre systems data flowing continuously into the Tidepool Data Platform. https://www.tidepool.org/blog/abbott-freestyle-libre-integration-launched XX Stelo dexom ai food XX With high drug prices remaining an ongoing concern for U.S. politicians, Roche is considering following in the footsteps of some of its peers with a direct-to-consumer (DTC) model to cut out the middlemen.     About 50% of the money spent on drugs in the U.S. healthcare system goes straight to PBMs instead of the companies that create the medicines, Roche CEO Thomas Schinecker called out in a press conference on Thursday.   Bringing the drugs directly to the consumer could be a solution to positively impact pricing for patients “without destroying innovation,” Schinecker added on a separate Thursday call with investors, noting that the company has discussed the matter with the U.S. government and its Department of Health and Human Services. The pricing talks come after President Donald Trump inked a “Most Favored Nation” executive order in May, aiming to tie U.S. drug prices to lower prices in other developed nations. The plan was quickly called out by industry voices such as the PhRMA trade group, which labeled it a “bad deal” for U.S. patients. https://www.fiercepharma.com/pharma/roche-weighing-direct-consumer-drug-sales-ease-us-drug-pricing-woes-cut-out-pbms-ceo-says XX SAB BIO secures substantial $175M financing to advance T1D therapy with impressive investor lineup and extended cash runway until 2028. Most critically, this financing fully funds the pivotal Phase 2b SAFEGUARD study evaluating SAB-142 for delaying progression of autoimmune Type 1 diabetes in newly diagnosed patients. By extending the cash runway into mid-2028, SAB has effectively eliminated near-term financing risk and provided clear visibility through this crucial clinical trial and potential commercialization preparation. Participation from strategic investor Sanofi, along with new investors RA Capital Management, Commodore Capital, Vivo Capital, Blackstone Multi-Asset Investing, Spruce Street Capital, Forge Life Science Partners and Woodline Partners LP, and existing investors Sessa Capital, the T1D Fund, and ATW Partners         https://www.stocktitan.net/news/SABS/sab-bio-announces-oversubscribed-175-million-private-fwsf2t91ek4z.html   XX In a landmark 14-year study, researchers have found that artificially sweetened drinks raise the risk of developing type 2 diabetes by more than a third, significantly higher than those loaded with sugar. It challenges the long-standing perception of diet drinks being a healthier alternative and suggests they may carry metabolic risks of their own. In the first longitudinal study of its kind, led by Monash University, researchers tracked 36,608 participants over an average period of 13.9 years to assess how both sugar-sweetened beverages (SSBs) and artificially sweetened beverages (ASBs) impacted health outcomes. The self-reported health data, from the Melbourne Collaborative Cohort Study, was drawn from participants aged 40 to 69 years at the time of recruitment.   What they found was that drinking just one can of artificially sweetened soda increased the risk of developing type 2 diabetes by 38%, compared to people who didn't consume these drinks at all. For those consuming the same amount of sugary drinks, the risk was 23% higher. This suggests there's more than obesity at play. The researchers believe this result is due to an independent metabolic effect, possibly gut microbiome disruption or a change in glucose metabolism.   While the study didn't identify which artificial sweeteners were at play,   Evidence suggests that artificial sweeteners can alter the composition and function of gut bacteria, leading to glucose intolerance – a precursor to type 2 diabetes. And that some sweeteners may trigger insulin release, desensitize metabolic responses over time, or confuse the body's glucose regulation system – even without actual sugar in the picture.   Another hypothesis is that regular exposure to the kind of intense sweetness that artificial products deliver may condition the body to anticipate sugar calories that never come, affecting appetite regulation, insulin sensitivity and broader metabolic pathways. However, the authors suggest that how sweeteners affect the gut microbiota and glucose regulation are the most likely drivers of increased diabetes risk.   https://newatlas.com/diet-nutrition/one-drink-diabetes-risk/ XX After months of deliberation, information gathering and public testimony, a state board unanimously agreed Monday that two common medications for type-2 diabetes and other conditions appear to pose an affordability challenge to the state and Marylanders.   The state Prescription Drug Affordability Board approved two resolutions saying that prescription drugs Jardiance and Farxiga likely pose an “an affordability challenge for the state health care system” and the state should look for ways to bring down those costs.   Health care advocates call the long-awaited resolution an “important first step” in the process in bringing down prescription costs for those on the state's health plan.       That milestone has been years in the making. Created in 2019 by the General Assembly, the Prescription Drug Affordability Board was slow to launch due in part to a veto from former Gov. Larry Hogan (R) amid pandemic-induced economic uncertainty in 2020 that delayed the board's formation. The board also cited out-of-pocket costs for consumers and state and local spending on those drugs as indicators that there may be an affordability challenge.   The board will now look at options to address the potential affordability challenge, which could include setting an upper payment limit on those drugs. But it's not clear when the state will see cost savings.   That said, some members of the health care system and the pharmaceutical industry say that policies such as upper payment limits could weaken access to life-saving drugs. Others say that the board has not engaged enough viewpoints from the health care industry. https://marylandmatters.org/2025/07/29/state-board-determines-two-type-2-diabetes-drugs-may-be-unaffordable/   XX One year after it was revealed that Chrissy Teigen and John Legend's son, Miles, was diagnosed with type 1 diabetes, Teigen is revealing how she's making her son feel more included. Teigen first opened up about her 7-year-old son's diagnosis after she and her two oldest kids, Miles and 9-year-old daughter Luna were at the 2024 summer Olympics cheering on Simone Biles. Teigen posted a photo of Miles and Luna holding up a sign. Also visible in the picture was the insulin pump on Miles' arm. Now, Teigen is sharing some insight into how she's making Miles more comfortable with having type 1 diabetes, including giving LeBron James' Barbie doll type 1 diabetes as well. In a video shared on Instagram, Teigen is seen taking the T1D Barbie, removing her insulin pump and gluing the pump onto LeBron James' Barbie. “Turning T1D Barbie into T1D Lebron James for my son,” Teigen captioned the video, revealing James is Miles' hero. 41 million followers https://www.yahoo.com/lifestyle/articles/chrissy-teigen-gives-lebron-james-154608782.html  

Gist Healthcare Daily
Friday, August 1, 2025

Gist Healthcare Daily

Play Episode Listen Later Aug 1, 2025 5:50


Healthcare and technology stakeholders pledge to make healthcare data sharing easier following a meeting at the White House. A federal judge blocks Arkansas's strict pharmacy benefit manager law. And, Swiss drugmaker Roche weighs direct-to-consumer drug sales. Those stories on today's episode of the Gist Healthcare podcast. Hosted on Acast. See acast.com/privacy for more information.

Spiritual Journey - Path to Awakening
Healing Begins Now: Fear, Energy Shifts, and the Power of Community with Lisa Roche

Spiritual Journey - Path to Awakening

Play Episode Listen Later Jul 30, 2025 63:45


In this heart-opening episode of the Spiritual Journey Podcast, host Nimesh Radia is joined by the radiant Lisa Roche—founder of Nagare Life and host of the Find Your Flow podcast—for a profound conversation about navigating the spiritual shift, healing through courage, and embracing the divine human experience.Lisa opens up about her deeply personal awakening journey, from facing debilitating physical challenges to receiving divine guidance that changed her life forever. Together, Nimesh and Lisa explore what it means to live in alignment during times of fear, the importance of sacred containers for healing, and how we can all begin to trust the quiet voice within. This episode is a soul-to-soul reminder that we are never alone, and the healing path often starts with one small act of courage.Together, Nimesh and Lisa explore:

BioSpace
Sarepta Gets Reprieve, RFK Jr.'s New Changes, Roche's Alzheimer's Comeback and Q2 Earnings

BioSpace

Play Episode Listen Later Jul 30, 2025 19:17


The Sarepta saga continued into another week as the FDA recommended that the voluntary hold on the company's Duchenne muscular dystrophy gene therapy be lifted for ambulatory patients, after determining that the death of an 8-year-old Brazilian Duchenne patient who had received Elevidys' was not caused by the drug.  Sarepta's stock has swung wildly and its transparency questioned after it elected not to reveal the death of a third patient—a participant in a trial of a gene therapy for limb girdle muscular dystrophy—during a business update last week.    Speaking of entities—or individuals—who have trouble staying out of the news, Health Secretary Robert F. Kennedy Jr. plans to dissolve the U.S. Preventive Services Task Force because it is “too woke.” Also on Monday, Kennedy addressed what he called the “broken” vaccine injury compensation program. Without offering details, he vowed to “fix” the U.S.'s VICP and return it to its “original Congressional intent.”   On the business side of the biopharma house, Q2 earnings are in full swing, with AstraZeneca announcing estimate-beating numbers and CEO Pascal Soriot saying the world “needs to share” in global pharma R&D, while Merck cut $3 billion to support an aggressive launch schedule. Meanwhile, a week ahead of its own earnings report, Novo Nordisk named a new CEO and lowered its 2025 sales guidance for the second time this year.   In clinical development, the Alzheimer's Association Annual Conference is underway in Toronto, with Roche's trontinemab the standout so far. In a Phase Ib/IIa trial, the next-gen anti-amyloid antibody rapidly cleared amyloid from the brains of patients with Alzheimer's disease after just seven months—besting the 18-month timeframe for Biogen and Eisai's Leqembi and Eli Lilly's Kisunla. While Leqembi and Kisunla have shown some progress is slowing down the progression of Alzheimer's, their effect size is modest and they don't work for all patients—leaving plenty of room for symptomatic treatments, such as those being developed by Bristol Myers Squibb and Acadia Pharmaceuticals. The space is gearing up for several readouts, for both symptomatic and disease-modifying therapies alike.   And in BioPharm Executive this week, we dig into the top VC rounds so far this year and highlight a few scrappy biotechs walking the solo road.  

L'info de la Loire
L'info de St Etienne et de la Loire à 08h du mercredi 30 juillet

L'info de la Loire

Play Episode Listen Later Jul 30, 2025 3:10


Ecoutez les infos de la Loire avec le flash info de 08h00 de ce mercredi 30 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha mercredi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 19h du mercredi 30 juillet

L'info de la Loire

Play Episode Listen Later Jul 30, 2025 2:31


Ecoutez les infos de la Loire avec le flash info de 19h00 de ce mercredi 30 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha mercredi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 18h du mercredi 30 juillet

L'info de la Loire

Play Episode Listen Later Jul 30, 2025 2:31


Ecoutez les infos de la Loire avec le flash info de 18h00 de ce mercredi 30 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha mercredi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 16h du mercredi 30 juillet

L'info de la Loire

Play Episode Listen Later Jul 30, 2025 2:31


Ecoutez les infos de la Loire avec le flash info de 16h00 de ce mercredi 30 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha mercredi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 12h du mercredi 30 juillet

L'info de la Loire

Play Episode Listen Later Jul 30, 2025 3:26


Ecoutez les infos de la Loire avec le flash info de 12h00 de ce mercredi 30 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha mercredi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 07h du mercredi 30 juillet

L'info de la Loire

Play Episode Listen Later Jul 30, 2025 3:13


Ecoutez les infos de la Loire avec le flash info de 07h00 de ce mercredi 30 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha mercredi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
Point of Relation with Thomas Huebl
Amandine Roche | Inner Peace for Collective Healing

Point of Relation with Thomas Huebl

Play Episode Listen Later Jul 29, 2025 52:37


Can healing yourself really help heal the world?This week, Thomas sits down with Amandine Roche, a human rights and women's empowerment expert with more than 20 years of experience with the United Nations and European Union. Amandine's extensive work in conflict zones worldwide was driven by a deep, personal quest for healing from childhood trauma. But the work itself took a toll on her mental and physical health, leading her on a journey of healing that uncovered an essential core truth that she now works to spread: we must have inner peace if we want to work for outer peace.Amandine shares beautifully honest details from her own personal struggles and offers a unique perspective on embracing femininity in human rights work and all forms of leadership. She and Thomas explore the need for collective spaces and new skills to digest world events and prevent the repetition of painful social and political patterns.It's an empowering conversation that highlights the absolute necessity of self-alignment and inner healing in humanitarian work and any type of effort toward peace and harmony in a world in crisis.✨ Click here to watch the video version of this episode on YouTube:

TruthWorks
How Bureaucracy is Killing Innovation, and How to Fix it! - Michele Zanini

TruthWorks

Play Episode Listen Later Jul 29, 2025 54:22


In this thought-provoking episode of Truth Works, organizational visionary Michele Zanini joins Jessica Neal and Bob Sutton to unpack the tyranny of bureaucracy and the bold promise of humanocracy. Co-author of the updated book Humanocracy, Michele explains why traditional management systems fail to inspire innovation, agility, or meaning—and how companies like Netflix, Roche, and even the U.S. Army are rewriting the rules.Together, they explore:Why companies become bureaucratic over timeThe flipside: unleashing resourceful people instead of controlling themRadical models of leadership, autonomy, and peer accountabilityHow culture is built through operating systems—not slogansIf you're a founder, HR leader, or executive trying to unshackle your team from inertia and unleash real human potential, this one is for you.

ANA Investigates
New and Emerging Therapies for Myasthenia Gravis

ANA Investigates

Play Episode Listen Later Jul 29, 2025 18:51


Today we'll focus on a major shift in the treatment of myasthenia gravis -- as a wave of new therapies is changing how we treat this disease. Who should be considered for these new treatments? And what else is in the pipeline?   Our guest today is Dr.  Gil Wolfe, a neuromuscular neurologist at the University of Buffalo State University of New York, Jacob School of Medicine and Biomedical Sciences. Dr. Wolfe was interviewed by Dr. Ioannis Karakis, adjunct professor of neurology at Emory University School of Medicine.   References: https://www.nature.com/articles/s41598-024-79918-7   Disclosures: Dr. Wolfe discloses: Consultant for: Alexion, Argenx, BPL, Cartesian, Canopy, Grifols, Johnson & Johnson, Takeda, UCB; Speaker Bureau for: Grifols, Alexion, UCB; Grant/Research support from: ArgenX, Ra/UCB, Immunovant, Roche, Alexion, Sanofi

L'info de la Loire
L'info de St Etienne et de la Loire à 19h du mardi 29 juillet

L'info de la Loire

Play Episode Listen Later Jul 29, 2025 2:22


Ecoutez les infos de la Loire avec le flash info de 19h00 de ce mardi 29 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha mardi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 18h du mardi 29 juillet

L'info de la Loire

Play Episode Listen Later Jul 29, 2025 2:22


Ecoutez les infos de la Loire avec le flash info de 18h00 de ce mardi 29 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha mardi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 16h du mardi 29 juillet

L'info de la Loire

Play Episode Listen Later Jul 29, 2025 2:22


Ecoutez les infos de la Loire avec le flash info de 16h00 de ce mardi 29 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha mardi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 12h du mardi 29 juillet

L'info de la Loire

Play Episode Listen Later Jul 29, 2025 3:25


Ecoutez les infos de la Loire avec le flash info de 12h00 de ce mardi 29 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha mardi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 08h du mardi 29 juillet

L'info de la Loire

Play Episode Listen Later Jul 29, 2025 3:18


Ecoutez les infos de la Loire avec le flash info de 08h00 de ce mardi 29 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha mardi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 07h du mardi 29 juillet

L'info de la Loire

Play Episode Listen Later Jul 29, 2025 3:14


Ecoutez les infos de la Loire avec le flash info de 07h00 de ce mardi 29 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha mardi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
Pharma and BioTech Daily
Pharma and Biotech Daily: Elevidys setback, Lilly's big commitment, and more!

Pharma and BioTech Daily

Play Episode Listen Later Jul 28, 2025 0:53


Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. The European Medicines Agency's CHMP did not recommend approving Elevidys for ambulatory patients with Duchenne muscular dystrophy, dealing a blow to Sarepta. FDA is rumored to request new data for Elevidys, leading to uncertainty as FDA considers a new study for the drug. In other news, Eli Lilly commits $856 million to Gate Bioscience for a new class of medicines, while Rocket trims headcount and pipeline focus. Roche also drops an early obesity asset as layoffs continue in the biopharma industry, with companies like Adicet optimizing their pipelines. Novartis makes a billion-dollar drug discovery deal with Matchpoint, and the FDA opens a pilot run of the commissioner voucher program.Stay tuned for more updates on the latest developments in the pharmaceutical and biotech world.

Mercado Abierto
Lo más destacado en Europa

Mercado Abierto

Play Episode Listen Later Jul 28, 2025 7:53


Analizamos los valores clave en el Viejo Continente de la mano de Pablo García, director general de Diovacons-Alphavalue. Miramos al pacto comercial entre la UE y EE.UU, el sector automovilístico, ST Micro, ASML, Infineon, Roche, Sanofi, Novartis, Heineken, Prosibiensat y Media for Europe.

L'info de la Loire
L'info de St Etienne et de la Loire à 07h du lundi 28 juillet

L'info de la Loire

Play Episode Listen Later Jul 28, 2025 3:09


Ecoutez les infos de la Loire avec le flash info de 07h00 de ce lundi 28 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha lundi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 08h du lundi 28 juillet

L'info de la Loire

Play Episode Listen Later Jul 28, 2025 3:04


Ecoutez les infos de la Loire avec le flash info de 08h00 de ce lundi 28 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha lundi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 12h du lundi 28 juillet

L'info de la Loire

Play Episode Listen Later Jul 28, 2025 3:38


Ecoutez les infos de la Loire avec le flash info de 12h00 de ce lundi 28 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha lundi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 16h du lundi 28 juillet

L'info de la Loire

Play Episode Listen Later Jul 28, 2025 2:27


Ecoutez les infos de la Loire avec le flash info de 16h00 de ce lundi 28 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha lundi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 18h du lundi 28 juillet

L'info de la Loire

Play Episode Listen Later Jul 28, 2025 2:27


Ecoutez les infos de la Loire avec le flash info de 18h00 de ce lundi 28 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha lundi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 19h du lundi 28 juillet

L'info de la Loire

Play Episode Listen Later Jul 28, 2025 2:27


Ecoutez les infos de la Loire avec le flash info de 19h00 de ce lundi 28 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha lundi gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 20h du dimanche 27 juillet

L'info de la Loire

Play Episode Listen Later Jul 27, 2025 2:02


Ecoutez les infos de la Loire avec le flash info de 20h00 de ce dimanche 27 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha dimanche gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
L'info de la Loire
L'info de St Etienne et de la Loire à 09h du dimanche 27 juillet

L'info de la Loire

Play Episode Listen Later Jul 27, 2025 2:02


Ecoutez les infos de la Loire avec le flash info de 09h00 de ce dimanche 27 juillet 2025. L'actualité à Saint-Etienne, Saint-Chamond, Roanne, Firminy, Montbrison, Rive-de-Gier, Saint-Just-Saint-Rambert, Le Chambon-Feugerolles, Riorges, Andrézieux-Bouthéon, Roche-la-Molière, Veauche, Unieux, Feurs, Villars, Sorbiers, La Ricamarie, Mably, Le Coteau, La Talaudière...Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

flash visitez roche juillet ausha dimanche gier loire moli ecoutez actu saint etienne rive act iv st etienne villars montbrison saint chamond firminy feurs activradio saint just saint rambert veauche
MorningBull
Des records et du chocolat qui reste sur l'estomac | Swiss Bliss

MorningBull

Play Episode Listen Later Jul 26, 2025 37:07


Cette semaine, on a tout eu : – Des entreprises qui explosent de +24% comme si c'était 2021, – D'autres qui s'écrasent à -17% pour avoir éternué de travers, – Des analystes qui changent d'objectif comme de chaussettes, – Et des marchés qui montent sur des mauvaises nouvelles… et parfois chutent sur des bonnes. C'est dire si on nage en pleine logique. - Et des marmottes qui risquent de perdre leur job... Mais ce n'est pas tout. ➡ Pendant que la tech s'envole à Wall Street, ➡ Trump menace à nouveau l'Europe de tarifs douaniers (comme si ça nous avait manqué), ➡ Et la Fed, elle, fait rien et elle ne refera rien la semaine prochaine Ajoute à ça un Japon qui revient de nulle part, une guerre commerciale qui s'étire façon Netflix saison 8, un pétrole qui hésite entre panique géopolitique et récession mondiale… et t'as un cocktail parfait pour une semaine où il faut VRAIMENT suivre ce qui se passe. Si t'en as marre des analyses plan-plan et que tu veux comprendre ce qui se joue vraiment dans la Bourse mondiale, t'es au bon endroit.

Pharma and BioTech Daily
Pharma and Biotech Update: Roche drops obesity asset, Novartis strikes deal, AstraZeneca's Phase III win, and more!

Pharma and BioTech Daily

Play Episode Listen Later Jul 25, 2025 0:56


Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Roche has dropped an early-stage obesity asset, CT-173, citing lack of competitiveness. Novartis has entered into a drug discovery deal with Matchpoint Therapeutics, acquiring global rights on all molecules for several inflammatory diseases. AstraZeneca claims a Phase III win with its nanobody treatment for myasthenia gravis. Second-quarter earnings season is approaching, and biotechs to watch include Sarepta and others facing challenges in the biopharma industry. Genentech downsizes as priorities shift, and GSK's comeback for Blenrep is on pause as the FDA delays its decision. The FDA's lack of transparency has tarnished Sarepta's reputation after patient deaths triggered an FDA battle. Opportunities in the industry include roles like Quality Specialist at CSL and Clinical Research Physician at Eli Lilly and Company.

10vor10
10 vor 10 vom 24.07.2025

10vor10

Play Episode Listen Later Jul 24, 2025 22:56


Roche nimmt Krebsmedikament Lunsumio vom Schweizer Markt, Schüsse auf Hilfskorridore in Gaza, «Earth Overshoot Day»: Wie nachhaltigeres Leben aussehen könnte, Neuverfilmung Superhelden-Saga «The Fantastic Four: First Steps»

Pharma and BioTech Daily
Pharma and Biotech Daily: FDA Voucher Program, Sarepta's Elevidys Halts, and AstraZeneca's $50 Billion Investment

Pharma and BioTech Daily

Play Episode Listen Later Jul 24, 2025 1:17


Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. The FDA has initiated a voucher program to address lower drug prices and boost domestic investment, with up to five companies being selected based on national priorities. Roche has halted shipments of Sarepta's Elevidys gene therapy after reports of patient deaths. Sarepta is under FDA scrutiny following a third patient death, while the agency welcomes a new top drug regulator and rejects multiple new drugs from entering the market. Insights from women in biopharma highlight the importance of resilience. Zhen Li, an engineer, is playing a crucial role in shaping the field of siRNA. Research suggests that GLP-1s may offer protection against neurodegenerative diseases. Dispatch Bio enters the scene with a substantial $216 million investment for universal CAR T therapy. Sarepta complies with an FDA request to suspend US shipments of Elevidys, raising concerns about transparency and impacting the company's reputation. Replimune experiences a significant drop in stock value following an FDA rejection, while AstraZeneca makes a bold $50 billion investment in US manufacturing to prepare for potential tariffs. Thank you for tuning in to Pharma and Biotech daily for the latest updates in the industry.

Moving Markets: Daily News
Progress in trade negotiations lift markets

Moving Markets: Daily News

Play Episode Listen Later Jul 24, 2025 11:02


Global equity markets rally on US-Japan trade deal progress, sparking hopes for EU agreements, with equities surging and gold easing. Japan's Nikkei 225 reaches a new all-time high, as does the S&P 500. In earnings: Alphabet surprises positively, while Tesla disappoints. Companies reporting today include industry giants like Nestle, Roche, Deutsche Bank, and LVMH. The ECB is not expected to cut rates today, with the market's focus on its outlook. Carsten Menke, Head of Next Generation Research, discusses China's historic new hydropower project – which is six times bigger than the Three Gorges Dam – and explores its potential impact on iron ore and steel prices.(00:00) - Introduction: Helen Freer, Investment Writing (00:25) - Markets wrap-up: Mike Rauber, Investment Writing (05:58) - Iron ore and steel: Carsten Menke, Head of Next Generation Research (09:51) - Closing remarks: Helen Freer, Investment Writing Would you like to support this show? Please leave us a review and star rating on Apple Podcasts, Spotify or wherever you get your podcasts.

BioSpace
Sarepta's Wild Week, CDER's New Leader, FDA Rejections, Manufacturing Billions

BioSpace

Play Episode Listen Later Jul 23, 2025 24:12


Just a few weeks ago, it seemed like Sarepta had weathered a spate of bad news, after two patients died from liver injuries from its Duchenne muscular dystrophy gene therapy Elevidys. Then came news of a third patient death. Last Wednesday, the company announced a major restructuring and 500-person layoff.  Then, in just a few days time, Sarepta Therapeutics went from enjoying a notable stock bump in response to that corporate update to its lowest price in nearly 10 years as it halts shipments of Elevidys. In addition to requesting the shipment hold, the FDA revoked the company's technology platform designation and paused all clinical trials for Sarepta's limb-girdle muscular dystrophy (LGMD) gene therapy. The turmoil was set in motion by media reports that a patient who received the LGMD treatment had died—a fact the company chose not to disclose during an investor call. In other news, the FDA's Center for Drug Evaluation and Research gets a new director in biotech veteran George Tidmarsh, also an adjunct professor of pediatrics and neonatology at Stanford University's School of Medicine. Tidmarsh enters the agency at a time of mass layoffs as well as voluntary departures. Meanwhile, Replimmune and Roche suffer FDA rejections as therapies from Otsuka/Lundbeck and GSK fail to earn adcomm support, as the bar for acceptable controls and demonstrations of efficacy continue to change under FDA commissioner Marty Makary and CBER director Vinay Prasad.  Finally, Big Pharmas continue to pump billions into U.S. manufacturing, with Biogen and AstraZeneca joining the list of companies to have made such pledges, pledging $2 billion and $50 billion, respectively. These latest announcements come as President Donald Trump reiterates that pharma-specific tariffs of up to 200% could come as soon as Aug. 1. 

The Innovation Show
Gary Hamel - Humanocracy Finale Reinventing Roche

The Innovation Show

Play Episode Listen Later Jul 22, 2025 58:37


In this episode, we conclude the comprehensive series on Gary Hamel and 'Humanocracy,' diving deep into the principles and practices that can transform entrenched bureaucracies into more dynamic and innovative organizations. Host Aidan interviews Gary Hamel to discuss the persistent issue of bureaucracy stifling economic growth and the groundbreaking transformation at Roche as a case study. The conversation covers the increasing bureaucracy in global companies, the decline in productivity, and innovative methods like outcome-based planning and cross-functional squads to elevate organizational efficiency. The episode also emphasizes personal accountability and offers actionable steps for leaders aiming to foster a more adaptive and resilient work environment. This informative discussion is a must-watch for CEOs and business leaders looking to revolutionize their companies.   00:00 Introduction and Giveaway Announcement 00:52 The Problem with Bureaucracy in Organizations 06:16 Case Study: Roche's Transformation 11:16 Leadership Reboot and Principles at Roche 20:31 Implementing Change: Design Teams and I Squads 26:34 Outcome-Based Planning and Resource Allocation 29:53 Resource Allocation and Organizational Ethos 31:16 Resilience in the Face of Challenges 32:59 Leadership and Change Management 37:47 Cross-Functional Squads and Collaboration 42:43 Patient-Centric Approach 46:31 Personal Accountability and Bureaucracy 50:30 Experimentation and Innovation 56:22 Conclusion and Final Thoughts   Find Gary 

The Simmer
Cindy Klein Roche, Chief Growth Officer, ezCater

The Simmer

Play Episode Listen Later Jul 22, 2025 43:51


Restaurant catering — and the tech that powers it — is hot, hot, hot. At nearly 20 years old, ezCater is poised to take advantage of the renewed interest from office workers and the restaurants that serve them. In this episode we talk about the evolution of catering, the tech that supports it, and why a little reassurance and hand-holding goes a long way with corporate clients. 

Pharma and BioTech Daily
Pharma and Biotech Daily: Navigating the Latest Industry News

Pharma and BioTech Daily

Play Episode Listen Later Jul 22, 2025 1:51


Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.George Tidmarsh, a biopharma veteran and adjunct professor at Stanford's medical school, has been appointed as the new head of the FDA's Center for Drug Evaluation and Research (CDER). His extensive industry experience will be valuable in his new government position. Data secrecy among cell and gene therapy developers is hindering progress in the field, causing fragmentation, stalling innovation, and delaying access to treatments. Meanwhile, Sarepta is facing challenges with its elevidys shipments and has lost platform designation for its technology. At the same time, Roche's phase III trial in COPD has failed, impacting the market path for astegolimab. Layoffs are happening at companies like GSK, Sail, and BioNTech. Experts are exploring new ways to overcome barriers in cell therapy production.Data secrecy among cell and gene therapy developers continues to hinder progress and access to treatments. Acadia has introduced a new team and pipeline with ambitious goals. Patients are fighting for access to Brainstorm's ALS drug after promising real-world data. Moderna's withdrawal of its flu vaccine has left combination flu/COVID-19 vaccines in limbo. In other news, Sarepta is facing challenges with its DMD gene therapy, Ultragenyx's gene therapy for Sanfilippo syndrome is rejected by the FDA, GSK's Blenrep loses an adcomm vote, and BMS' anemia drug Reblozyl fails a Phase III trial. The FDA is experiencing layoffs and employee turnover amid an overhaul. Vinay Prasad overruled reviewers on Moderna's COVID-19 shot for kids. Upcoming events include a webinar on AI for real-world research and job opportunities in the biopharma industry. Readers are encouraged to provide feedback and suggest topics for future coverage.

Appels sur l'actualité
[Vos questions] Niger: la plus grosse roche de Mars vendue aux enchères

Appels sur l'actualité

Play Episode Listen Later Jul 21, 2025 19:30


Les journalistes et experts de RFI répondent également à vos questions sur les investissements chinois en Afrique, le trafic illégal de bois russe en Europe et le remaniement gouvernemental en Ukraine. Niger : la plus grosse roche de Mars vendue aux enchères  Découverte en 2021 dans la région d'Agadez, au nord du Niger, une météorite d'origine martienne a été vendue ce 17 juillet aux enchères à New York pour 5,3 millions de dollars. Une transaction record pour un fragment extraterrestre. Comment cette roche de Mars a-t-elle été découverte ? Le Niger a-t-il tiré un bénéfice économique ou scientifique de cette découverte ? Avec Welly Diallo, journaliste au service Afrique de RFI. Investissements chinois : opportunité pour l'Afrique ou nouvelle tutelle étrangère ?   La Chine multiplie ses investissements sur le continent africain avec 39 milliards de dollars en 2025. Ces investissements représentent-ils une réelle opportunité pour le développement de l'Afrique ? Peut-on y voir une nouvelle forme de dépendance ? Avec Emmanuel Véron, enseignant-chercheur associé à l'Inalco, spécialiste de la Chine.  Union européenne : trafic illégal de bois russe malgré les sanctions  Malgré les sanctions imposées à la Russie, des millions d'euros de bois illégal continuent d'affluer vers l'Union européenne. Comment expliquer l'entrée de ce bois russe en Europe ? Pourquoi les pays comme la Turquie, la Géorgie ou la Chine sont-ils utilisés comme points de transit dans ce trafic de bois ? Avec Yang Mei, journaliste au service environnement-climat et au service en langue chinoise de RFI.  Ukraine : la nouvelle Première ministre sous le feu des critiques  Volodymyr Zelensky a opéré un remaniement gouvernemental en nommant Ioulia Svyrydenko au poste de Première ministre, pourtant très critiquée à cause de sa proximité avec le président. En quoi sa nomination pourrait-elle renforcer l'influence de Zelensky sur le gouvernement ? Avec Adrien Nonjon, chercheur spécialiste de l'Ukraine. 

Regionaljournal Basel Baselland
Tigermücke: Tessiner Bekämpfungsmethode noch kein Thema

Regionaljournal Basel Baselland

Play Episode Listen Later Jul 21, 2025 5:32


Der Kanton Tessin geht bei der Bekämpfung der Tigermücke neue Wege. In Basel beobachtet man diese neue Bekämpfungsmethode derzeit noch. Ob sie hier je zum Einsatz kommt, sei noch offen, heisst es auf Anfrage beim Basler Gesundheitsdepartement. Ausserdem: · Rückschlag für Roche bei der Erforschung eines Lungenmedikaments · Prozess am Strafgericht Muttenz

Positive Talk Radio
1,122 | Find Your Flow: Lisa Roche on Feng Shui, Reiki & Creating Healing Energy in Your Life

Positive Talk Radio

Play Episode Listen Later Jul 17, 2025 61:03


Pharma and BioTech Daily
Pharma and Biotech Daily: Insights from the Industry Leaders

Pharma and BioTech Daily

Play Episode Listen Later Jul 17, 2025 1:25


Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Johnson & Johnson reported second-quarter earnings of $23.7 billion, driven by cancer and neuroscience drugs, exceeding analyst expectations. CEO Joaquin Duato set a target of $50 billion in oncology sales by 2030. Despite challenges in the industry, Johnson & Johnson remains optimistic about its oncology sales target as the biotech industry continues to navigate the evolving landscape of drug development and funding.In a difficult investing environment where IPOs are not guaranteed, AI-focused biotech unicorns are facing challenges in securing funding. GSK's Blenrep is facing setbacks as the FDA questions its efficacy in treating multiple myeloma, while AstraZeneca's amyloidosis asset failed to improve survival in a late-stage trial. The industry is also seeing the rise of women leaders like Audrey Greenberg and the team at Acadia, who are making significant contributions to the field.Biospace is launching a new weekly newsletter focused on critical manufacturing issues in the biopharma industry, covering developments and impacts on companies such as Roche, Sanofi, and Johnson & Johnson. The newsletter aims to provide deep dives, analysis, and roundups of the biggest manufacturing stories of the week every Tuesday. Stay informed with weekly analysis and updates on the changing landscape of manufacturing in the U.S.

Regionaljournal Basel Baselland
Roche nimmt Krebsmedikament vom Markt

Regionaljournal Basel Baselland

Play Episode Listen Later Jul 17, 2025 23:27


Weil sich das Basler Pharmaunternehmen Roche und das Bundesamt für Gesundheit nicht auf einen Preis für das Krebsmedikament einigen konnten, nimmt es die Roche nun vom Markt. Ausserdem: · Neues Festival in Hölstein verbindet elektronische und klassische Musik · "Sicher ist sicher": Die Geschichte der Schweizer Bunker

Radio Maria Ireland
Chatechesis – Carmela – Michael Roche – Alpha as tool to renew the Church

Radio Maria Ireland

Play Episode Listen Later Jul 17, 2025 39:57


Carmela from the Belfast office chats with Michael Roche who tells of his journey to Alpha and how he now helps others to become disciples. L'articolo Chatechesis – Carmela – Michael Roche – Alpha as tool to renew the Church proviene da Radio Maria.

Leadership Is Changing
763: Leadership is Changing Mashup 2025 (ft Dr. Nadya Zhexembayeva and Ken Miller)

Leadership Is Changing

Play Episode Listen Later Jul 16, 2025 21:06


What does it truly mean to lead when the world around you crumbles and rebuilds itself?This episode features host Denis Gianoutsos' most powerful conversations with two extraordinary leaders. Dr. Nadya Zhexembayeva, born to political dissidents in Soviet Kazakhstan, witnessed her world collapse overnight—yet discovered that leadership is a dynamic space we enter and exit, not a fixed title. Ken Miller, a healthcare executive with 32 years of global experience, reveals the athletic mindset required for modern leadership and why our most outstanding teachers are found in our closest relationships, not boardrooms.Join Denis Gianoutsos for this transformative mashup—your perspective on leadership may never be the same.EP 221 - Dr. Nadya Zhexembayeva: Leadership as a Dynamic Space: From Soviet Collapse to Revolutionary ThinkingBorn in Soviet Kazakhstan to political dissidents, witnessed sudden USSR collapse, creating a complete vacuumRedefines leadership as a space you enter and exit daily, not a fixed title or position.Draws from Kazakh nomadic culture,e viewing leadership as a dynamic circle larger than any individualIdentifies daughter and parents as most significant leadership influences, emphasizing self-love before leading othersEP 225 - Ken Miller: Healthcare Leadership and the Athletic Mindset: Building Legacy Through Purpose32 years in healthcare at companies like Sanofi, Pfizer, Roche, choosing impact over just profitDescribes leaders as athletes - highly competitive with a tireless appetite for success and sacrificeEmphasizes continuous learning and personal development rather than relying on organizationsCites Dr. Martin Luther King Jr. as a favorite leader for authenticity and fighting for something bigger than himselfKey Quotes:"Leadership for me is a space. You enter and exit many times a day." - Dr. Nadya Zhexembayeva"You've gotta have a work ethic, which is second to none, to really have an impact around the world." - Ken MillerThe 10 Proven Ways to Lead and Thrive in Today's World - FREE Executive Guide Download https://crm.leadingchangepartners.com/10-ways-to-lead Connect with Denis:Email: denis@leadingchangepartners.comWebsite: www.LeadingChangePartners.com Facebook: https://www.facebook.com/denisgianoutsos LinkedIn: https://www.linkedin.com/in/denisgianoutsos/ Instagram: https://www.instagram.com/leadershipischanging/ YouTube Channel: https://www.youtube.com/@DenisGianoutsos

Au cœur de l'histoire
[2/2] Albert Roche, le héros oublié de la Première Guerre mondiale

Au cœur de l'histoire

Play Episode Listen Later Jul 15, 2025 11:53


Cet été, retrouvez le meilleur d'Au cœur de l'Histoire, avec Virginie Girod ! Le 11 novembre 1918, l'armistice est signé dans la clairière de Rethondes, à Compiègne, mettant fin à la première guerre totale de l'Histoire. Après la victoire, l'on rend hommage à ceux qui ont servi la patrie au péril de leur vie. Parmi eux, se trouve Albert Roche (1885-1939), jeune paysan originaire de la Drôme qui aurait capturé pas moins de 1180 soldats allemands à lui seul, bravant la peur et la mort dans l'enfer des tranchées. Le 27 novembre, à Strasbourg, il est décoré par le maréchal Foch qui le surnomme "le premier soldat de France". Mais quelle est la part du mythe dans l'incroyable histoire des exploits d'Albert Roche ?Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Au cœur de l'histoire
[1/2] Albert Roche, le héros oublié de la Première Guerre mondiale

Au cœur de l'histoire

Play Episode Listen Later Jul 14, 2025 14:37


Cet été, retrouvez le meilleur d'Au cœur de l'Histoire, avec Virginie Girod ! À l'occasion de la fête national, découvrez ou redécouvrez l'histoire d'un héros français oublié. Le 28 juin 1914, l'assassinat de l'archiduc François-Ferdinand d'Autriche met le feu aux poudres et plonge l'Europe dans la Première Guerre mondiale. Alors qu'en France, la mobilisation est annoncée, un jeune paysan de la Drôme veut partir au front et servir sa patrie. Exempté de service militaire à cause d'un physique chétif, Albert Roche (1885-1939) force le destin et parvient à être envoyé en première ligne, au sein du 27e bataillon des chasseurs alpins. Agé de vingt ans, le jeune soldat se livre alors à de remarquables faits d'armes.Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

RTÉ - An Saol ó Dheas
Roche Ó hUallacháin agus Susan Feirtéar

RTÉ - An Saol ó Dheas

Play Episode Listen Later Jul 11, 2025 6:48


Baill den lucht eagraíochta do Fhéile an Phráta.

NEVER STRAYS FAR
TDF STAGE FIVE: SOFT NORMANDY LANDINGS

NEVER STRAYS FAR

Play Episode Listen Later Jul 9, 2025 35:59


A tome trial preview featuring most of the Roche dynasty.Sign up to BIKMO for the best bike insurance in the world!Sign up and show your support to NSF - Live in France! Hosted on Acast. See acast.com/privacy for more information.